Cytokinetics, Incorporated

CYTK · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$225,467$74,940$73,680$94,857
Short-Term Investments$737,068$783,195$864,538$981,157
Receivables$1,808$8,410$2,012$16,650
Inventory$0$0$0$0
Other Curr. Assets$13,006$19,997$15,823$15,276
Total Curr. Assets$977,349$886,542$956,053$1,107,940
Property Plant & Equip (Net)$153,581$146,339$144,614$140,973
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$288,817$178,201$150,687$145,055
Tax Assets$0$0$0$0
Other NC Assets$16,810$14,553$12,697$7,705
Total NC Assets$459,208$339,093$307,998$293,733
Other Assets$0$0$0$0
Total Assets$1,436,557$1,225,635$1,264,051$1,401,673
Liabilities
Payables$22,084$16,228$13,942$20,369
Short-Term Debt$37,927$33,985$32,534$30,498
Tax Payable$0$0$0$0
Deferred Revenue$1,612$1,344$52,370$52,370
Other Curr. Liab.$80,521$79,507$60,880$76,437
Total Curr. Liab.$142,144$131,064$159,726$179,674
LT Debt$1,158,926$824,073$758,521$758,179
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$656,610$639,218$612,217$599,192
Total NC Liab.$1,815,536$1,463,291$1,370,738$1,357,371
Other Liabilities$0$0$0$0
Cap. Leases$110,655$130,613$132,927$131,560
Total Liabilities$1,957,680$1,594,355$1,530,464$1,537,045
Equity
Pref Stock$0$0$0$0
Common Stock$122$119$119$118
Retained Earnings-$3,303,688-$2,997,510-$2,863,140-$2,701,764
AOCI$34-$158$1,545$2,398
Other Equity$2,782,409$2,628,829$2,595,063$2,563,876
Total Equity-$521,123-$368,720-$266,413-$135,372
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,436,557$1,225,635$1,264,051$1,401,673
Net Debt$971,386$783,118$717,375$693,820